AI Article Synopsis
- Polycaprolactone-based fillers are widely used in plastic surgery for facial enhancement, but they can lead to serious complications like arterial embolism, a rare condition.
- A 35-year-old woman experienced an arterial embolism after getting a polycaprolactone filler at her nasal base and was successfully treated with a regimen involving 5-fluorouracil.
- Through ultrasound, the treatment showed significant improvement in blood flow and, after long-term follow-up, nearly eliminated facial scarring with no adverse reactions noted.
Article Abstract
Polycaprolactone-based fillers are commonly used in plastic surgery to improve facial aging. However, adverse vascular events following these injections have been reported. An arterial embolism is a rare but serious complication associated with injectable filler procedures. We report a case of arterial embolism in a 35-year-old woman who received a polycaprolactone-based dermal filler at the nasal base and was treated with a regimen containing 5-fluorouracil. We discuss the potential causes of the patient's condition and assess the superiority of our method over conventional approaches. Before treatment, ultrasound detected a decreased flow velocity in the patient's right medial canthus artery with distal hypoperfusion, which improved significantly posttreatment. Long-term follow-up revealed near-disappearance of facial scarring. Our treatment effectively addressed facial artery embolism without any reported adverse reactions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11379482 | PMC |
| http://dx.doi.org/10.1097/GOX.0000000000006140 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!